{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T02:40:04Z","timestamp":1772851204258,"version":"3.50.1"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T00:00:00Z","timestamp":1715904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,26]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Patients with long-term chronic illnesses frequently present with hypogonadism, which is primarily managed through exogenous testosterone. These same patients also experience a high degree of cachexia, a loss of skeletal muscle and adipose tissue.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To perform a contemporary review of the literature to assess the effectiveness of testosterone replacement therapy (TRT) for managing chronic disease\u2013associated cachexia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We performed a PubMed literature search using MeSH terms to identify studies from 2000 to 2022 on TRT and the following cachexia-related chronic medical diseases: cancer, COPD, HIV\/AIDS, and liver cirrhosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>From the literature, 11 primary studies and 1 meta-analysis were selected. Among these studies, 3 evaluated TRT on cancer-associated cachexia, 3 on chronic obstructive pulmonary disease, 4 on HIV and AIDS, and 2 on liver cirrhosis. TRT showed mixed results favoring clinical improvement on each disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Cachexia is commonly observed in chronic disease states. Its occurrence with hypogonadism, alongside the shared symptoms of these 2 conditions, points toward the management of cachexia through the administration of exogenous testosterone. Robust data in the literature support the use of testosterone in increasing lean body mass, improving energy levels, and enhancing the quality of life for patients with chronic disease. However, the data are variable, and further studies are warranted on the long-term efficacy of TRT in patients with cachexia.<\/jats:p><\/jats:sec>","DOI":"10.1093\/sxmrev\/qeae031","type":"journal-article","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T10:14:21Z","timestamp":1715940861000},"page":"469-476","source":"Crossref","is-referenced-by-count":4,"title":["Testosterone replacement therapy in patients with cachexia: a contemporary review of the literature"],"prefix":"10.1093","volume":"12","author":[{"given":"Seyed Sajjad","family":"Tabei","sequence":"first","affiliation":[{"name":"Division of Urology , Department of Surgery, , Cincinnati, OH 45267 , United States"},{"name":"College of Medicine, University of Cincinnati , Department of Surgery, , Cincinnati, OH 45267 , United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhea","family":"Kataria","sequence":"additional","affiliation":[{"name":"Pritzker School of Medicine, The University of Chicago Medical Center , Chicago, IL 60637 , United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Hou","sequence":"additional","affiliation":[{"name":"Pritzker School of Medicine, The University of Chicago Medical Center , Chicago, IL 60637 , United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armaan","family":"Singh","sequence":"additional","affiliation":[{"name":"Pritzker School of Medicine, The University of Chicago Medical Center , Chicago, IL 60637 , United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan","family":"Al Hameedi","sequence":"additional","affiliation":[{"name":"Section of Urology , Department of Surgery, Pritzker School of Medicine, , Chicago, IL 60637 , United States"},{"name":"The University of Chicago Medical Center , Department of Surgery, Pritzker School of Medicine, , Chicago, IL 60637 , United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doaa","family":"Hasan","sequence":"additional","affiliation":[{"name":"Section of Urology , Department of Surgery, Pritzker School of Medicine, , Chicago, IL 60637 , United States"},{"name":"The University of Chicago Medical Center , Department of Surgery, Pritzker School of Medicine, , Chicago, IL 60637 , United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mike","family":"Hsieh","sequence":"additional","affiliation":[{"name":"Department of Urology, University of California San Diego , San Diego, CA 921212 , United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omer A","family":"Raheem","sequence":"additional","affiliation":[{"name":"Section of Urology , Department of Surgery, Pritzker School of Medicine, , Chicago, IL 60637 , United States"},{"name":"The University of Chicago Medical Center , Department of Surgery, Pritzker School of Medicine, , Chicago, IL 60637 , United States"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,5,17]]},"reference":[{"key":"2024070101065191800_ref1","volume-title":"Cachexia","author":"Rogers, Syed","year":"2024"},{"issue":"4","key":"2024070101065191800_ref2","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/MAJ.0000000000000511","article-title":"Mechanisms of cachexia in chronic disease states","volume":"350","author":"Yoshida","year":"2015","journal-title":"Am J Med Sci"},{"issue":"4","key":"2024070101065191800_ref3","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/ajcn\/83.4.735","article-title":"Cachexia: pathophysiology and clinical relevance","volume":"83","author":"Morley","year":"2006","journal-title":"Am J Clin Nutr"},{"issue":"11","key":"2024070101065191800_ref4","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nrc927","article-title":"Cachexia in cancer patients","volume":"2","author":"Tisdale","year":"2002","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"2024070101065191800_ref5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s13539-012-0065-7","article-title":"Hypogonadism in male cancer patients","volume":"3","author":"Burney","year":"2012","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"7","key":"2024070101065191800_ref6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12032-017-0982-6","article-title":"Clinical significance of androgen secretion disorders in men with a malignancy","volume":"34","author":"Wiechno","year":"2017","journal-title":"Med Oncol"},{"issue":"3","key":"2024070101065191800_ref7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MOG.0000000000000261","article-title":"Cause and management of muscle wasting in chronic liver disease","volume":"32","author":"Dasarathy","year":"2016","journal-title":"Curr Opin Gastroenterol"},{"issue":"2","key":"2024070101065191800_ref8","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/MCP.0b013e32834feb37","article-title":"Hypogonadism in chronic obstructive pulmonary disease: incidence and effects","volume":"18","author":"Balasubramanian","year":"2012","journal-title":"Curr Opin Pulm Med"},{"issue":"3","key":"2024070101065191800_ref9","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ecl.2014.06.005","article-title":"Hypogonadism in the HIV-infected man","volume":"43","author":"Rochira","year":"2014","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"5","key":"2024070101065191800_ref10","doi-asserted-by":"crossref","first-page":"E700","DOI":"10.1210\/jc.2011-2387","article-title":"Low testosterone levels and increased inflammatory markers in patients with cancer and relationship with cachexia","volume":"97","author":"Burney","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2024070101065191800_ref11","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/jcsm.12295","article-title":"A randomized trial of adjunct testosterone for cancer-related muscle loss in men and women","volume":"9","author":"Wright","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"2024070101065191800_ref12","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/jcsm.12716","article-title":"Androgen replacement therapy for cancer-related symptoms in male: result of prospective randomized trial (ARTFORM study)","volume":"12","author":"Izumi","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"9","key":"2024070101065191800_ref13","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1007\/s00520-013-1832-5","article-title":"Testosterone replacement for fatigue in hypogonadal ambulatory males with advanced cancer: a preliminary double-blind placebo-controlled trial","volume":"21","author":"Del Fabbro","year":"2013","journal-title":"Support Care Cancer"},{"key":"2024070101065191800_ref14","doi-asserted-by":"crossref","first-page":"1479972318793004","DOI":"10.1177\/1479972318793004","article-title":"Testosterone replacement therapy and hospitalization rates in men with COPD","volume":"16","author":"Baillargeon","year":"2019","journal-title":"Chron Respir Dis"},{"issue":"8","key":"2024070101065191800_ref15","doi-asserted-by":"crossref","first-page":"e003127","DOI":"10.1136\/bmjopen-2013-003127","article-title":"Endogenous testosterone level and testosterone supplementation therapy in chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis","volume":"3","author":"Atlantis","year":"2013","journal-title":"BMJ Open"},{"issue":"2","key":"2024070101065191800_ref16","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1177\/0884533614522832","article-title":"Study of body composition, lung function, and quality of life following use of anabolic steroids in patients with chronic obstructive pulmonary disease","volume":"29","author":"Daga","year":"2014","journal-title":"Nutr Clin Pract"},{"issue":"2","key":"2024070101065191800_ref17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3810\/pgm.2013.03.2638","article-title":"Testosterone replacement therapy in men with hypogonadism and HIV\/AIDS: results from the TRiUS registry","volume":"125","author":"Blick","year":"2013","journal-title":"Postgrad Med"},{"issue":"6","key":"2024070101065191800_ref18","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1001\/jama.283.6.763","article-title":"Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels","volume":"283","author":"Bhasin","year":"2000","journal-title":"JAMA"},{"issue":"1","key":"2024070101065191800_ref19","first-page":"60","article-title":"Effects of hypogonadism and testosterone administration on depression indices in HIV-infected men","volume":"85","author":"Grinspoon","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2024070101065191800_ref20","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S1473-3099(02)00441-3","article-title":"Testosterone therapy in HIV wasting syndrome: systematic review and meta-analysis","volume":"2","author":"Kong","year":"2002","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"2024070101065191800_ref21","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.clinre.2011.09.005","article-title":"Effects of testosterone gel treatment in hypogonadal men with liver cirrhosis","volume":"35","author":"Yurci","year":"2011","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"5","key":"2024070101065191800_ref22","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jhep.2016.06.007","article-title":"Testosterone therapy increases muscle mass in men with cirrhosis and low testosterone: a randomised controlled trial","volume":"65","author":"Sinclair","year":"2016","journal-title":"J Hepatol"},{"issue":"6","key":"2024070101065191800_ref23","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin Nutr"},{"issue":"2","key":"2024070101065191800_ref24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s13539-011-0027-5","article-title":"The cachexia score (CASCO): a new tool for staging cachectic cancer patients","volume":"2","author":"Argil\u00e9s","year":"2011","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"2024070101065191800_ref25","article-title":"A pound of flesh: what cachexia is and what it is not","volume":"11","author":"Berardi","year":"2021","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"2024070101065191800_ref26","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1186\/s12885-018-5080-4","article-title":"Pharmacological management of cachexia in adult cancer patients: a systematic review of clinical trials","volume":"18","author":"Advani","year":"2018","journal-title":"BMC Cancer"},{"issue":"1","key":"2024070101065191800_ref27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/jcsm.12062","article-title":"Cachexia in chronic obstructive pulmonary disease: new insights and therapeutic perspective","volume":"7","author":"Sanders","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"6","key":"2024070101065191800_ref28","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.3390\/cells11061039","article-title":"Interconnection between cardiac cachexia and heart failure-protective role of cardiac obesity","volume":"11","author":"Soto","year":"2022","journal-title":"Cells"},{"issue":"4","key":"2024070101065191800_ref29","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1002\/jcsm.13260","article-title":"Kidney function in cachexia and sarcopenia: facts and numbers","volume":"14","author":"Okamura","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"2024070101065191800_ref30","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/QAD.0000000000003096","article-title":"HIV-associated wasting prevalence in the era of modern antiretroviral therapy","volume":"36","author":"Siddiqui","year":"2022","journal-title":"AIDS"},{"issue":"4","key":"2024070101065191800_ref31","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/SPC.0b013e3283196ac2","article-title":"Role of the ubiquitin-proteasome pathway in muscle atrophy in cachexia","volume":"2","author":"Attaix","year":"2008","journal-title":"Curr Opin Support Palliat Care"},{"issue":"5","key":"2024070101065191800_ref32","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41577-021-00624-w","article-title":"The interplay of immunology and cachexia in infection and cancer","volume":"22","author":"Baazim","year":"2022","journal-title":"Nat Rev Immunol"},{"issue":"43","key":"2024070101065191800_ref33","doi-asserted-by":"crossref","first-page":"e389942","DOI":"10.1200\/EDBK_389942","article-title":"Current therapeutic targets in cancer cachexia: a pathophysiologic approach","volume":"43","author":"Kadakia","year":"2023","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"4","key":"2024070101065191800_ref34","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1002\/mco2.164","article-title":"Targeting cancer cachexia: molecular mechanisms and clinical study","volume":"3","author":"Wang","year":"2022","journal-title":"MedComm (2020)"},{"issue":"3","key":"2024070101065191800_ref35","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/jcsm.12126","article-title":"Espindolol for the treatment and prevention of cachexia in patients with stage III\/IV non-small cell lung cancer or colorectal cancer: a randomized, double-blind, placebo-controlled, international multicentre phase II study (the ACT-ONE trial)","volume":"7","author":"Stewart Coats","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"3","key":"2024070101065191800_ref36","first-page":"CD004310","article-title":"Megestrol acetate for treatment of anorexia-cachexia syndrome","volume":"2019","author":"Ruiz Garcia","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"2024070101065191800_ref37","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/13685538.2018.1482487","article-title":"The relationship between circulating testosterone and inflammatory cytokines in men","volume":"22","author":"Mohamad","year":"2019","journal-title":"Aging Male"},{"issue":"1","key":"2024070101065191800_ref38","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1210\/jc.2005-1097","article-title":"Correlation between testosterone and the inflammatory marker soluble interleukin-6 receptor in older men","volume":"91","author":"Maggio","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2024070101065191800_ref39","volume":"8","journal-title":"PLoS One"},{"issue":"1","key":"2024070101065191800_ref40","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0303-7207(01)00394-X","article-title":"Chemokines control fat accumulation and leptin secretion by cultured human adipocytes","volume":"175","author":"Gerhardt","year":"2001","journal-title":"Molecular and Cellular Endocrinology"},{"issue":"1","key":"2024070101065191800_ref41","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1210\/endo-124-1-410","article-title":"Testosterone raises neuropeptide-Y concentration in selected hypothalamic sites and in vitro release from the medial basal hypothalamus of castrated male rats","volume":"124","author":"Sahu","year":"1989","journal-title":"Endocrinology"},{"issue":"9","key":"2024070101065191800_ref42","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.nut.2008.06.020","article-title":"Cachexia and neuropeptide Y","volume":"24","author":"Morley","year":"2008","journal-title":"Nutrition"},{"issue":"2","key":"2024070101065191800_ref43","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa2215025","article-title":"Cardiovascular safety of testosterone-replacement therapy","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"issue":"1","key":"2024070101065191800_ref44","doi-asserted-by":"crossref","first-page":"360","DOI":"10.4102\/sajp.v73i1.360","article-title":"The relationship between lower limb muscle strength and lower extremity function in HIV disease","volume":"73","author":"Mhariwa","year":"2017","journal-title":"S Afr J Physiother"},{"issue":"1","key":"2024070101065191800_ref45","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41572-020-0181-1","article-title":"HIV and antiretroviral therapy-related fat alterations","volume":"6","author":"Koethe","year":"2020","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"2024070101065191800_ref46","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/jgh.12695","article-title":"Testosterone in men with advanced liver disease: abnormalities and implications","volume":"30","author":"Sinclair","year":"2015","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Sexual Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/smr\/article-pdf\/12\/3\/469\/58334999\/qeae031.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/smr\/article-pdf\/12\/3\/469\/58334999\/qeae031.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T17:51:45Z","timestamp":1731779505000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/smr\/article\/12\/3\/469\/7673985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,17]]},"references-count":46,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,5,17]]},"published-print":{"date-parts":[[2024,6,26]]}},"URL":"https:\/\/doi.org\/10.1093\/sxmrev\/qeae031","relation":{},"ISSN":["2050-0513","2050-0521"],"issn-type":[{"value":"2050-0513","type":"print"},{"value":"2050-0521","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,7]]},"published":{"date-parts":[[2024,5,17]]}}}